ROUSTRIN F (Rosuvastatin 20 mg and Fenofibrate 160 mg)

May 30, 2023

Introduction

ROUSTRIN F 20 is a combination medication containing Rosuvastatin (20 mg) and Fenofibrate (160 mg), which is primarily used to manage lipid abnormalities, including high cholesterol and triglyceride levels. The medication plays a crucial role in preventing cardiovascular diseases, particularly in patients with dyslipidemia, a condition characterized by abnormal levels of lipids (fats) in the blood. This combination is often prescribed to patients who have not achieved desired results from lifestyle changes alone, such as diet and exercise.

Both Rosuvastatin and Fenofibrate have been individually studied and proven effective in lowering cholesterol and triglyceride levels. Together, they form a potent therapeutic option for managing lipid profiles and promoting heart health.

In this article, we will explore the key ingredients of ROUSTRIN F 20, its mechanism of action, uses, dosage, side effects, and precautions.

Key Ingredients in ROUSTRIN F 20

Rosuvastatin (20mg)

Rosuvastatin is a statin drug, belonging to a class of medications known as HMG-CoA reductase inhibitors. This enzyme plays a vital role in the production of cholesterol in the liver. By inhibiting HMG-CoA reductase, Rosuvastatin reduces the liver’s ability to produce cholesterol, thereby lowering overall cholesterol levels in the bloodstream.

Mechanism of Action

Rosuvastatin works by blocking the enzyme HMG-CoA reductase, which is essential for cholesterol production. This reduction in cholesterol production leads to increased uptake of low-density lipoprotein (LDL, often referred to as "bad cholesterol") from the bloodstream, helping to decrease its levels. As a result, it lowers LDL cholesterol and total cholesterol levels in the body.

Rosuvastatin has also been shown to increase high-density lipoprotein (HDL, or "good cholesterol") levels, which helps protect the cardiovascular system. Additionally, it has mild effects on lowering triglycerides.

Uses

  • Hypercholesterolemia: Rosuvastatin is commonly prescribed for patients with high cholesterol levels, helping to prevent heart attacks and strokes.
  • Prevention of Cardiovascular Events: It reduces the risk of heart disease and related complications in individuals with a history of cardiovascular events or those at risk.
  • Dyslipidemia: For patients with high cholesterol and abnormal lipid levels, Rosuvastatin is an essential treatment.
  • Atherosclerosis: Rosuvastatin is used to reduce plaque formation in the arteries and prevent further cardiovascular damage.

Fenofibrate (160mg)

Fenofibrate is a fibric acid derivative, a class of drugs designed to treat abnormal cholesterol levels. It is particularly effective in reducing triglycerides and increasing HDL cholesterol. Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs), which help regulate lipid metabolism.

Mechanism of Action

Fenofibrate activates PPARs, which play a role in regulating the breakdown and removal of lipids from the bloodstream. By stimulating these receptors, Fenofibrate increases the metabolism of fatty acids and triglycerides, lowering their levels in the body. Fenofibrate is especially effective in reducing triglycerides and increasing HDL cholesterol, providing benefits for overall heart health.

Uses

  • Hypertriglyceridemia: Fenofibrate is prescribed to lower triglyceride levels, which, when elevated, increase the risk of cardiovascular diseases.
  • Mixed Dyslipidemia: Fenofibrate is effective in treating patients who have both high cholesterol and high triglycerides.
  • Low HDL Cholesterol: Fenofibrate helps raise HDL cholesterol levels, which is protective against heart disease.
  • Prevention of Atherosclerosis: By reducing triglycerides and increasing HDL cholesterol, Fenofibrate helps prevent the buildup of plaque in arteries.

How Does ROUSTRIN F 20 Work?

The combination of Rosuvastatin and Fenofibrate in ROUSTRIN F 20 works synergistically to improve lipid metabolism and cardiovascular health. Rosuvastatin reduces LDL cholesterol, while Fenofibrate primarily works to lower triglycerides and increase HDL cholesterol. Together, these effects contribute to a healthier lipid profile and a lower risk of cardiovascular events, such as heart attack, stroke, and atherosclerosis.

The medication works in the following ways:

  • Lowering LDL Cholesterol: Rosuvastatin reduces the production of LDL cholesterol in the liver, which helps to reduce the accumulation of plaque in the arteries.
  • Reducing Triglycerides: Fenofibrate increases the breakdown of triglycerides, lowering their levels in the bloodstream.
  • Raising HDL Cholesterol: Fenofibrate also helps raise HDL cholesterol, which is beneficial for heart health and aids in the removal of excess cholesterol from the bloodstream.
  • Improving Overall Lipid Profile: By reducing LDL and triglycerides while increasing HDL, ROUSTRIN F 20 helps balance the lipid profile, promoting heart health.

Dosage and Administration

The usual dose of ROUSTRIN F 20 is one tablet taken once a day, typically with or without food. The medication is often prescribed for long-term use, and it is important to take it consistently as directed by the healthcare provider.

Dosage Considerations

  • Starting Dose: The starting dose may be adjusted based on individual cholesterol and triglyceride levels, as well as the patient's response to treatment.
  • Monitoring: Regular monitoring of cholesterol levels, liver function, and kidney function is essential during treatment with ROUSTRIN F 20 to ensure efficacy and safety.
  • Missed Dose: If a dose is missed, it should be taken as soon as remembered, unless it is close to the time for the next dose. In this case, skip the missed dose and continue the regular schedule.

Precautions

  • Liver and Kidney Function: ROUSTRIN F 20 should be used cautiously in individuals with liver or kidney problems. Liver function tests may be required to monitor for potential side effects.
  • Pregnancy and Breastfeeding: ROUSTRIN F 20 should not be used during pregnancy or breastfeeding unless prescribed by a healthcare provider, as the effects on the fetus or infant are not well understood.
  • Drug Interactions: Patients should inform their healthcare provider about all other medications they are taking, including over-the-counter drugs, supplements, and herbal remedies, as there may be potential interactions with ROUSTRIN F 20.
  • Alcohol: Excessive alcohol consumption should be avoided during treatment, as it may increase the risk of liver toxicity.

Side Effects

As with any medication, ROUSTRIN F 20 may cause side effects. However, not everyone will experience them, and many side effects are mild and temporary. Common side effects include:

  • Muscle pain or weakness (due to Rosuvastatin)
  • Digestive issues, such as nausea, diarrhea, or abdominal pain
  • Headache
  • Fatigue
  • Dizziness

In rare cases, serious side effects may occur, including:

  • Rhabdomyolysis: A condition involving muscle breakdown that can lead to kidney damage
  • Liver damage: Indicated by jaundice, dark urine, or upper stomach pain
  • Severe allergic reactions: Rash, itching, or swelling of the face, lips, or throat

If any of these severe side effects occur, immediate medical attention should be sought.

Contraindications

ROUSTRIN F 20 should not be used in the following situations:

  • Active liver disease: Individuals with active liver disease or unexplained liver enzyme elevations should avoid using ROUSTRIN F 20.
  • Severe kidney impairment: Those with severe renal impairment should not take this combination without close supervision.
  • Pregnancy and breastfeeding: ROUSTRIN F 20 should not be used by pregnant or breastfeeding women due to the potential risks to the baby.
  • Allergy to Statins or Fibrates: Patients with a known allergy to Rosuvastatin or Fenofibrate should not use this medication.

Conclusion

ROUSTRIN F 20, a combination of Rosuvastatin (20mg) and Fenofibrate (160mg), provides an effective solution for managing high cholesterol and triglyceride levels in patients with dyslipidemia. By lowering LDL cholesterol, raising HDL cholesterol, and reducing triglycerides, this combination helps reduce the risk of cardiovascular diseases, including heart attacks and strokes. Patients taking ROUSTRIN F 20 should follow their healthcare provider's recommendations, monitor for side effects, and maintain a healthy lifestyle to achieve optimal results.

In addition to the direct effects of lowering cholesterol and triglycerides, the use of ROUSTRIN F 20 emphasizes the importance of cardiovascular health and the prevention of atherosclerosis, contributing to a longer and healthier life for individuals with lipid abnormalities.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW

SHARE WITH